XML 13 R2.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 25,256 $ 24,570
Short-term marketable securities 70,656 89,024
Accounts receivable, prepaid expenses and other current assets 4,680 12,357
Total current assets 100,592 125,951
Marketable securities 71,297 90,302
Property and equipment, net 811 1,008
Other assets 2,834 3,066
Total assets 175,534 220,327
Current liabilities:    
Accounts payable 9,187 4,690
Accrued expenses 9,784 20,333
Deferred income 3,925 3,890
Other current liabilities 2,735 2,683
Total current liabilities 25,631 31,596
Other liabilities 1,711 4,439
Deferred income, net of current portion 17,492 20,038
Contingent consideration 10,600 8,700
Total liabilities 55,434 64,773
Stockholders' Equity:    
Preferred stock, $0.00001 par value; 10,000,000 shares authorized and no shares issued or outstanding at September 30, 2025 and December 31, 2024
Common stock, $0.00001 par value; 400,000,000 and 200,000,000 shares authorized at September 30, 2025 and December 31, 2024, respectively; 108,342,592 and 107,850,124 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively 1 1
Additional paid-in capital 1,067,491 1,058,317
Accumulated other comprehensive income 597 97
Accumulated deficit (947,989) (902,861)
Total stockholders' equity 120,100 155,554
Total liabilities and stockholders' equity $ 175,534 $ 220,327